Skip to main content

. 1991 Apr;81(4):414–415. doi: 10.2105/ajph.81.4.414

The cost-effectiveness of orphan drugs.

PMCID: PMC1405048 PMID: 1900676

414

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Drummond M. F. Economic evaluation and the rational diffusion and use of health technology. Health Policy. 1987 Jun;7(3):309–324. doi: 10.1016/0168-8510(87)90072-8. [DOI] [PubMed] [Google Scholar]
Hay J. W., Robin E. D. Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease. Am J Public Health. 1991 Apr;81(4):427–433. doi: 10.2105/ajph.81.4.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kinosian B. P., Eisenberg J. M. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia. JAMA. 1988 Apr 15;259(15):2249–2254. doi: 10.1001/jama.259.15.2249. [DOI] [PubMed] [Google Scholar]
Weinstein M. C., Stason W. B. Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health. 1985;6:41–63. doi: 10.1146/annurev.pu.06.050185.000353. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES